164 related articles for article (PubMed ID: 29531462)
1. Dysregulation of PARP1 is involved in development of Barrett's esophagus.
Zhang C; Ma T; Luo T; Li A; Gao X; Wang ZG; Li F
World J Gastroenterol; 2018 Mar; 24(9):982-991. PubMed ID: 29531462
[TBL] [Abstract][Full Text] [Related]
2. Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells.
Peng D; Belkhiri A; Hu T; Chaturvedi R; Asim M; Wilson KT; Zaika A; El-Rifai W
Gut; 2012 Sep; 61(9):1250-60. PubMed ID: 22157330
[TBL] [Abstract][Full Text] [Related]
3. In Barrett's epithelial cells, weakly acidic bile salt solutions cause oxidative DNA damage with response and repair mediated by p38.
Huo X; Dunbar KB; Zhang X; Zhang Q; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G464-G478. PubMed ID: 31984785
[TBL] [Abstract][Full Text] [Related]
4. In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids.
Peng S; Huo X; Rezaei D; Zhang Q; Zhang X; Yu C; Asanuma K; Cheng E; Pham TH; Wang DH; Chen M; Souza RF; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G129-39. PubMed ID: 24852569
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1.
Streppel MM; Pai S; Campbell NR; Hu C; Yabuuchi S; Canto MI; Wang JS; Montgomery EA; Maitra A
Clin Cancer Res; 2013 Aug; 19(15):4067-78. PubMed ID: 23757351
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
[TBL] [Abstract][Full Text] [Related]
7. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus.
Dvorak K; Payne CM; Chavarria M; Ramsey L; Dvorakova B; Bernstein H; Holubec H; Sampliner RE; Guy N; Condon A; Bernstein C; Green SB; Prasad A; Garewal HS
Gut; 2007 Jun; 56(6):763-71. PubMed ID: 17145738
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
Matkarimov BT; Zharkov DO; Saparbaev MK
Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of glycoursodeoxycholic acid in Barrett's esophagus cells.
Goldman A; Condon A; Adler E; Minnella M; Bernstein C; Bernstein H; Dvorak K
Dis Esophagus; 2010 Feb; 23(2):83-93. PubMed ID: 19549210
[TBL] [Abstract][Full Text] [Related]
10. In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks.
Zhang HY; Hormi-Carver K; Zhang X; Spechler SJ; Souza RF
Cancer Res; 2009 Dec; 69(23):9083-9. PubMed ID: 19920191
[TBL] [Abstract][Full Text] [Related]
11. Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells.
Huo X; Juergens S; Zhang X; Rezaei D; Yu C; Strauch ED; Wang JY; Cheng E; Meyer F; Wang DH; Zhang Q; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G278-86. PubMed ID: 21636532
[TBL] [Abstract][Full Text] [Related]
12. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
Buttar NS; Wang KK; Anderson MA; Dierkhising RA; Pacifico RJ; Krishnadath KK; Lutzke LS
J Natl Cancer Inst; 2002 Mar; 94(6):422-9. PubMed ID: 11904314
[TBL] [Abstract][Full Text] [Related]
13. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines.
Feagins LA; Zhang HY; Zhang X; Hormi-Carver K; Thomas T; Terada LS; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G411-7. PubMed ID: 18063706
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.
Shirvani VN; Ouatu-Lascar R; Kaur BS; Omary MB; Triadafilopoulos G
Gastroenterology; 2000 Mar; 118(3):487-96. PubMed ID: 10702199
[TBL] [Abstract][Full Text] [Related]
16. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure.
Hao Y; Sood S; Triadafilopoulos G; Kim JH; Wang Z; Sahbaie P; Omary MB; Lowe AW
BMC Gastroenterol; 2007 Jun; 7():24. PubMed ID: 17597535
[TBL] [Abstract][Full Text] [Related]
17. Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus.
Zhang HY; Zhang X; Chen X; Thomas D; Hormi-Carver K; Elder F; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G470-8. PubMed ID: 18617556
[TBL] [Abstract][Full Text] [Related]
18. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence.
O'Farrell NJ; Feighery R; Picardo SL; Lynam-Lennon N; Biniecka M; McGarrigle SA; Phelan JJ; MacCarthy F; O'Toole D; Fox EJ; Ravi N; Reynolds JV; O'Sullivan J
BMC Cancer; 2016 Jul; 16():497. PubMed ID: 27431913
[TBL] [Abstract][Full Text] [Related]
19. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia.
Wang DH; Clemons NJ; Miyashita T; Dupuy AJ; Zhang W; Szczepny A; Corcoran-Schwartz IM; Wilburn DL; Montgomery EA; Wang JS; Jenkins NA; Copeland NA; Harmon JW; Phillips WA; Watkins DN
Gastroenterology; 2010 May; 138(5):1810-22. PubMed ID: 20138038
[TBL] [Abstract][Full Text] [Related]
20. Clinical Study of Ursodeoxycholic Acid in Barrett's Esophagus Patients.
Banerjee B; Shaheen NJ; Martinez JA; Hsu CH; Trowers E; Gibson BA; Della'Zanna G; Richmond E; Chow HH
Cancer Prev Res (Phila); 2016 Jul; 9(7):528-33. PubMed ID: 26908564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
